These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24065265)

  • 1. How to measure substantia nigra hyperechogenicity in Parkinson disease: detailed guide with video.
    Walter U
    J Ultrasound Med; 2013 Oct; 32(10):1837-43. PubMed ID: 24065265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
    Toomsoo T; Liepelt-Scarfone I; Kerner R; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
    J Ultrasound Med; 2016 Jan; 35(1):17-23. PubMed ID: 26589647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feature analysis for Parkinson's disease detection based on transcranial sonography image.
    Chen L; Hagenah J; Mertins A
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):272-9. PubMed ID: 23286140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new assessment tool for Parkinson disease: the nigral lesion load obtained by transcranial sonography.
    Sanzaro E; Iemolo F; Duro G; Malferrari G
    J Ultrasound Med; 2014 Sep; 33(9):1635-40. PubMed ID: 25154946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcranial sonography for the diagnosis of Parkinson disease].
    Venegas F P; Miranda G G; Silva C MC
    Rev Med Chil; 2011 Jan; 139(1):54-9. PubMed ID: 21526317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.
    Schweitzer KJ; Hilker R; Walter U; Burghaus L; Berg D
    Mov Disord; 2006 Jan; 21(1):94-8. PubMed ID: 16114024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of substantia nigra echogenicity in German and Filipino populations using a portable ultrasound system.
    Go CL; Frenzel A; Rosales RL; Lee LV; Benecke R; Dressler D; Walter U
    J Ultrasound Med; 2012 Feb; 31(2):191-6. PubMed ID: 22298861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of substantia nigra echogenicities in 3D transcranial ultrasound for early diagnosis of Parkinson disease.
    Pauly O; Ahmadi SA; Plate A; Boetzel K; Navab N
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):443-50. PubMed ID: 23286161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
    Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
    Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inversion recovery MRI in idiopathic Parkinson disease is a very sensitive tool to assess neurodegeneration in the substantia nigra: preliminary investigation.
    Raff U; Hutchinson M; Rojas GM; Huete I
    Acad Radiol; 2006 Jun; 13(6):721-7. PubMed ID: 16679274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonographic alteration of substantia nigra is related to parkinsonism-predominant course of X-linked dystonia-parkinsonism.
    Walter U; Rosales R; Rocco A; Westenberger A; Domingo A; Go CL; Brüggemann N; Klein C; Lee LV; Dressler D
    Parkinsonism Relat Disord; 2017 Apr; 37():43-49. PubMed ID: 28094105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial sonography of the substantia nigra: digital image analysis.
    Skoloudík D; Jelínková M; Blahuta J; Cermák P; Soukup T; Bártová P; Langová K; Herzig R
    AJNR Am J Neuroradiol; 2014 Dec; 35(12):2273-8. PubMed ID: 25059698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound.
    Subramanian T; Lieu CA; Guttalu K; Berg D
    Ultrasound Med Biol; 2010 Apr; 36(4):604-9. PubMed ID: 20211515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the substantia nigra by means of transcranial ultrasound imaging].
    Vivo-Orti MN; Tembl JI; Sastre-Bataller I; Vazquez-Costa JF; Sahuquillo P; Burguera JA
    Rev Neurol; 2013 Mar; 56(5):268-74. PubMed ID: 23440754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
    López Hernández N; García Escrivá A; Shalabi Benavent M
    Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.